(0.07%) 5 520.75 points
(0.11%) 39 887 points
(0.18%) 19 786 points
(0.00%) $81.63
(0.43%) $2.82
(-0.30%) $2 337.40
(0.08%) $29.55
(0.32%) $1 005.00
(0.02%) $0.932
(0.00%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
12.50% $ 2.88
Live Chart Being Loaded With Signals
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions...
Stats | |
---|---|
Dzisiejszy wolumen | 165 201 |
Średni wolumen | 28 345 |
Kapitalizacja rynkowa | 1.28M |
EPS | $-7.06 ( Q1 | 2024-03-31 ) |
Następna data zysków | ( $-3.79 ) 2024-08-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.220 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0830 (2.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-04 | Mento Steven J | Buy | 10 000 | Stock Option (Right to Buy) |
2024-01-04 | Proehl Gerald T | Buy | 125 000 | Stock Option (right to buy) |
2024-01-04 | Fisher Mary | Buy | 10 000 | Stock Option (Right to Buy) |
2024-01-04 | Scott Kathleen D. | Buy | 10 000 | Stock Option (Right to Buy) |
2024-01-04 | Sandler Andrew Seth | Buy | 10 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 98 transactions |
Buy: 8 169 572 | Sell: 872 238 |
Wolumen Korelacja
Dermata Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dermata Therapeutics, Korelacja - Waluta/Towar
Dermata Therapeutics, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-39.98 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-39.98 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-13.92 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.43 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Dermata Therapeutics,
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej